Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) EV-to-Revenue

: 2.36 (As of Today)

View and export this data going back to 2010. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Takeda Pharmaceutical Co's enterprise value is $69,480 Mil. Takeda Pharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $29,415 Mil. Therefore, Takeda Pharmaceutical Co's EV-to-Revenue for today is 2.36.

The historical rank and industry rank for Takeda Pharmaceutical Co's EV-to-Revenue or its related term are showing as below:

TAK' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.94 Med: 2.66 Max: 5.73
Current: 2.36

During the past 13 years, the highest EV-to-Revenue of Takeda Pharmaceutical Co was 5.73. The lowest was 1.94. And the median was 2.66.

TAK's EV-to-Revenue is ranked worse than
54.78% of 1026 companies
in the Drug Manufacturers industry
Industry Median: 2.33 vs TAK: 2.36

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-19), Takeda Pharmaceutical Co's stock price is $13.16. Takeda Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $9.33. Therefore, Takeda Pharmaceutical Co's PS Ratio for today is 1.41.

Takeda Pharmaceutical Co EV-to-Revenue Historical Data

The historical data trend for Takeda Pharmaceutical Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EV-to-Revenue

5.75

2.92

3.09

2.50

2.63

Takeda Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue																2.52	2.63	2.78	2.80	2.57

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Takeda Pharmaceutical Co EV-to-Revenue Distribution

For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Takeda Pharmaceutical Co's EV-to-Revenue falls into.

Takeda Pharmaceutical Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Takeda Pharmaceutical Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	69480.473	/	29415.171
	=	2.36

Takeda Pharmaceutical Co's current Enterprise Value is $69,480 Mil.
Takeda Pharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $29,415 Mil.

Takeda Pharmaceutical Co (NYSE:TAK) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Takeda Pharmaceutical Co's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	13.16	/	9.333
	=	1.41

Takeda Pharmaceutical Co's share price for today is $13.16.
Takeda Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $9.33.

Takeda Pharmaceutical Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (NYSE:TAK) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

TKPHF:USA TAK:Mexico 4502:Japan 4502:Japan 4502:Japan 4502:Japan TKDA:Germany TKD:Germany TKD:Germany TAKP34:Brazil

Address

1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668

Website

https://www.takeda.com

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.